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Abstract Fractional flow reserve (FFR) is an index
of the physiological significance of a coronary
stenosis. Patients who have lesions with a FFR of
[0.80, even optimally treated with medication, have
however a MACE rate ranging from 8 to 21%.
Coronary plaques at high risk of rupture and clinical
events can be also identified by virtual histology
intravascular ultrasound (IVUS-VH) as plaques with
high amount of necrotic core (NC) abutting the lumen.
Aim of this exploratory study was to investigate
whether the geometry and composition of lesions with
FFR B 0.80 were different from their counterparts.
Fifty-five consecutive patients in whom FFR was
clinically indicated on a moderate angiographic
lesion, received also an imaging investigation on the
same lesion with IVUS-VH. Data on plaque geometry
and composition was analyzed. Patients were subdi-
vided in two groups according to the value of FFR ([
or B0.80). Lesions with a FFR B 0.80 (n = 17)
showed a slightly larger plaque burden than those with
FFR [ 0.80 (n = 38) (54.6 ± 0.7% vs. 51.7 ± 0.7%
P = 0.1). In addition, they tend to have less content of
necrotic core than their counterparts (14.2 ± 8% vs.
19.2 ± 10.2%, P = 0.08). No difference was found in
the distribution of NC-rich plaques (fibroatheroma
and thin-capped fibroatheroma) between groups (82%
in FFR B 0.80 vs. 79% in FFR [ 0.80, P = 0.5).
Although FFR B 0.80 lesions have larger plaque size,
they do not differ in composition from the ones with
FFR [ 0.80. Further exploration in a large prospec-
tive study is needed to study whether the lesions with
FFR [ 0.80 that are NC rich are the ones associated
with the presence of clinical events at follow-up.
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Introduction
The presence of myocardial ischemia is an important
risk factor for an adverse clinical outcome [1].
Revascularization of stenotic coronary lesions that
induce ischemia can improve patient’s functional
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status and outcome [1, 2]. For stenotic lesions that do
not induce ischemia, however, the benefit of revas-
cularization is less clear, and medical therapy alone is
likely to be equally effective [3, 4].
Fractional flow reserve (FFR) is an index of the
physiological significance of a coronary stenosis and
is defined as the ratio of maximal blood flow in a
stenotic artery to normal maximal flow [5]. A FFR
value of 0.80 or less identifies ischemia-causing
coronary stenoses with accuracy of more than 90%
[5, 6]. Plaques at high risk of rupture and provoking
coronary events appear to have high amount of
necrotic core [7–10] and this feature can be readily
identified by virtual histology intravascular ultra-
sound (IVUS-VH) [11].
Aim of our study was to explore whether the
geometry and composition of lesions with FFR B 0.80
were different from their counterparts.
Methods
In this exploratory study, all consecutive patients,
exhibiting an angiographically moderate lesion on
one coronary vessel, admitted from January 2009 to
January 2010 in whom FFR was clinically indicated
[12, 13], underwent on the same lesion an IVUS-VH
analysis to investigate the relationship between
functional and morphological/compositional lesion
characteristics.
Quantitative coronary angiography analysis
Quantitative coronary angiography (QCA) analyses
were performed by one experienced independent
observer, blinded to FFR, IVUS-VH and clinical data,
using the CAAS II analysis system (Pie Medical BV,
Maastricht, Netherlands). The following QCA param-
eters were computed: computer-defined minimum
lumen diameter (MLD), reference vessel diameter
(RVD) obtained by the interpolate method, and
percentage diameter stenosis [14].
IVUS-VH acquisition and plaque-type
classification
The IVUS was performed using the Eagle Eye
20 MHz catheter (Volcano Corp., Rancho Cordova,
California) with an automatic continuous pullback at
a rate of 0.5 mm/s (30 frames/sec) at level of the
lesion evaluated by FFR. Grayscale images and
radiofrequency data required for VH analysis were
acquired during the same pullback and raw radiofre-
quency data capture gated to the R wave (In-Vision
Gold, Volcano). The VH processing was performed
offline with pcVH 2.1 software (Volcano Corp.,
Rancho Cordova, California) that permits semi-auto-
mated contours detection and provides the composi-
tional structure of the vessel. Quantitative IVUS
measurements included vessel area, lumen area,
plaque area (vessel area minus lumen area) and
plaque burden ([plaque area/vessel area] 9 100). For
the radiofrequency-IVUS analyses, four tissue com-
ponents (necrotic core—red; dense calcium—white;
fibrous—dark green; and fibrofatty—light green)
were identified with autoregressive classification
systems. Each individual tissue component was
quantified and color-coded in IVUS cross sections,
as previously described [7, 15].
Lesions were classified by 2 experienced and
independent observers, blinded to FFR data, based on
plaque composition in 3 consecutive frames within
the lesion, as previously described [16]: pathological
intimal thickening (PIT), thin-cap fibroatheroma
(TCFA), calcified fibroatheroma (CAFA), thick-
capped fibroatheroma (ThFA), calcified thick-cap
fibroatheroma (CATHFA), fibrotic plaque and fibro-
calcific plaque [17, 18]. In case of disagreement, a
consensus was reached between the two observers.
PIT consisted of mainly a mixture of fibrous and
fibrofatty tissue plaque with\10% confluent necrotic
core and\10% confluent dense calcium. TCFA was a
fibroatheroma without evidence of a fibrous cap:
[10% confluent necrotic core with [30 necrotic
core in contact with the lumen. Calcified fibroather-
oma was a fibroatheroma with[10% confluent dense
calcium. ThFA was a fibroatheroma ([10% of
confluent necrotic core) with a definable fibrous
cap. CATHFA was a ThFA with [10% confluent
dense calcium. Fibrotic plaque (FT) consisted of
mainly fibrous tissue with \10% confluent necrotic
core, \15% fibrofatty tissue and \10% confluent
dense calcium. Fibrocalcific plaque (FC) was com-
posed of nearly all fibrous tissue and dense calcium
with \10% confluent necrotic core. All the plaques
with [10% of necrotic core were also classified as
NC-rich plaques.
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FFR evaluation
The FFR evaluation was done according to the
current guidelines [12, 13]. The FFR was measured
with a coronary pressure guidewire (Radi, St.Jude
Medical, Uppsala, Sweden) at maximal hyperemia
induced by intravenous adenosine, administered at
140 lg/kg/min through a periferical vein. FFR is
calculated as the mean distal coronary pressure
(measured with the pressure wire) divided by the
mean aortic pressure (measured simultaneously with
the guiding catheter) during maximal hyperemia [19].
In the case of diffuse atherosclerosis punctuated by
focal areas of more severe stenosis, or in the case of
more than one stenosis within the same artery,
pressure pullback recordings during hyperemia were
performed as described previously [13, 20]. In
addition, whenever another significant lesion was
detected within the same vessel it was recommended
by protocol that the FFR measurements should be
performed after this lesion had been treated.
Statistical analysis
Categorical variables were expressed as counts and
percentage. Group differences of categorical vari-
ables were compared using chi-square or fisher-exact
test, as appropriate. Continuous variables were
expressed as mean ± standard deviation (SD). The
normal distribution of the variables was explored by
Kolgomorov-Smirnov test. As the variables were not
normally distributed, comparison between groups
was done by non parametric tests. A P value of
\0.05 was considered significant, and all tests were
two-tailed. Data were analyzed with SPSS version
16.0 software (SPSS Inc., Chicago, IL).
Results
Baseline clinical and angiographic characteristics
Fifty-five consecutive patients were enrolled in the
study. Table 1 shows their clinical and angiographic
characteristics. All the patients included had only
one-vessel disease, that was investigated by FFR and
IVUS-VH analyses. In particular 17 out of these
patients (31%) showed a FFR B 0.80 and 13 patients
(23%) received stent implantation on the lesion
evaluated by FFR. The remaining 4 patients did not
receive any treatment for the following reasons: the
minimum lumen area by IVUS was [4 mm2 in 3
patients and the FFR was 0.79 in 1 patient. The 38
patients with a FFR C 0.80 did not receive any
revascularization treatment and were treated by
medical therapy.
QCA analysis confirmed that all the lesions
included in the analysis were angiographically mod-
erate lesions (46% mean stenosis), for which the FFR
evaluation is indicated according to guidelines.
Patients with a FFR C 0.80 exhibited higher RVD
and MLD than those patients with a FFR B 0.80
(Table 1).
IVUS geometrical analysis (Table 2)
Plaque burden was slightly larger for those lesions
with a FFR B 0.80 (54.6 ± 0.7% vs. 51.7 ± 0.7%
P = 0.1) accompanied with a reduction in lumen area
(7.1 ± 1.8 mm2 vs. 7.9 ± 2.4 mm2, P = 0.1) and
without expansion of the vessel area as compared to
their counterparts (16.0 ± 5.0 mm2 vs. 16.5 ± 4.4
mm2, P = 0.4). Minimum lumen area was lower for
those lesions with a FFR B 0.80 than those with a
FFR [ 0.80 (P = 0.07).
IVUS-VH analysis
Table 2 shows the compositional IVUS-VH data.
Plaques with FFR B 0.80 showed higher relative
content of fibrofatty tissue (P = 0.02) and a trend
towards a lower relative content of necrotic core
(P = 0.08) compared to plaques with FFR [ 0.80.
Plaque classification yielded good concordance
between the two observers (j = 0.85). Overall, we
found 9 PIT, 2 FC, 7 FA, 6 CaFA, 9 TCFA and 22
CaTCFA (Fig. 1). No difference was found in the
distribution of VH-plaque type between the two
groups (Fig. 2). NC-rich plaque distribution was also
not different between groups (82% in FFR B 0.80 vs.
79% in FFR [ 0.80, P = 0.5).
Discussion
The major finding of this analysis is that, although
larger plaques are associated with FFR B 0.80, VH-
plaque composition and VH-plaque type are not
Int J Cardiovasc Imaging
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different between lesions with FFR more or equal/
less than 0.80.
From previous studies it is known that patients,
who have lesions with a FFR [ 0.80, if optimally
treated with medication, have a good prognosis up to
5-years [4]. However, the MACE rate of these
patients may range from 8 to 21% [21–25]. We set
out this exploratory study to investigate whether
plaque composition could be one of the reasons to
explain this occurrence of events if these lesions are
left untreated, based on FFR findings. Interestingly,
QCA already discriminates in our analysis the lesions
with a FFR B 0.80 which have smaller MLD and
RVD compared with lesions with a FFR C 0.80.
However, it appears that although FFR B 0.80
lesions are more stenotic and have larger size, they
do not differ in composition from the ones with
FFR [ 0.80 and left untreated. Rogers et al. [26]
demonstrated a heterogeneous VH-plaque type mor-
phology with prevalence of TCFA in FFR-negative
lesions. In our study, comparing FFR negative and
positive lesions, we found that the relative content of
NC seems to be higher in lesions with a FFR [ 0.80
(P = 0.08). This could be a possible explanation of
MACE for those patients with angiographically
intermediate lesions, left untreated as no functionally
significant by FFR ([0.80) [21]. In addition, lesions
with FFR B 0.80 exhibited higher fibrofatty tissue
content than those lesions with FFR C 0.80
(P = 0.02). This tissue, corresponding to lipids
without necrosis, is namely present in PIT, that have
been shown able to evolve in VH-fibroatheroma [27].
From pathological studies it is known that specific
coronary plaques characteristics, such thin fibrous
cap, paucity of smooth muscle cells, heavy inflam-
matory infiltration of the cap and large necrotic cores
correlate with fatal ischemic events [28]. The recent
PROSPECT trial has also shown that thin-capped
fibroatheroma, identified by IVUS-VH, is a strong
independent predictor of events at 3-year follow-up
[11]. Angiographic studies before and after myocar-
dial infarction showed that pre-existing lesions at the
sites of myocardial infarction are not usually accom-
panied by hemodinamically significant stenosis [29].
In sudden coronary death, at least 50% of the
thrombosis occurred at lesion sites with B50%
Table 1 Clinical and angiographic characteristics
Patients (n = 55)







Mean ± SD (n)
61 ± 10 61 ± 9 60 ± 12 0.24
Men (%) 83 81 88 0.70
Smokers (%) 56 55 58 1.00
Diabetes (%) 12 15 5 0.41
Hypertension requiring medication (%) 63 65 58 0.76
Hyperlipidaemia requiring medication (%) 69 68 70 1.00
Stable angina (%) 69 71 65 0.75
Unstable angina (%) 30 29 35 0.63
Target vessel (%) 0.98
Left anterior descending 65 65 64
Left circumflex 16 15 18
Right coronary artery 18 20 18
QCA analysis
MLD (mm) 1.66 ± 0.37 1.76 ± 0.34 1.43 ± 0.34 0.03
RVD (mm) 3.14 ± 0.52 3.25 ± 0.54 2.90 ± 0.39 0.03
% stenosis 46.1 ± 0.9 45.2 ± 0.8 49.0 ± 0.1 0.16
FFR 0.84 ± 0.08 NA NA NA
SD standard deviation, QCA quantitative coronary angiography, MLD minimum lumen diameter, RVD reference vessel diameter,
FFR fractional flow reserve
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angiographic diameter reduction [30]. However, we
cannot elucidate from our study whether the lesions
with FFR [ 0.80 that are NC rich (77% of them) are
the ones associated with the presence of clinical
events at follow-up. This hypothesis needs further
exploration in a larger prospective study.
On the other side, Kubo et al. [27] showed recently
that there are various possible pathways in the
evolution and stabilization of NC-rich plaques. At
12-month follow-up they found that most of the NC-
rich plaques healed or stabilized. The mechanism of
healing is not well established. The transformation of
hematoma and/or thrombus into fibrous muscular
tissue and the formation or increase in thickness of
the fibrous cap could lead to plaque stabilization [31].
Some studies have proposed that a silent rupture or a
plaque rupture proximal to a lesion might lead to
mural thrombus and subsequent formation of a
fibrotic cap over the TCFA [32, 33]. This could be
the natural evolution of the NC-rich plaques for
lesions with a FFR more than 0.80, as the good
prognosis of these patients. In addition, it is note-
worthy to consider that a large minimum lumen area
could also favor a silent NC-rich plaque rupture,
allowing a coronary flow sufficient to avoid a clinical
event. In our study, we found, indeed, a lower
minimal lumen area in FFR B 0.80 lesions as
compared to FFR [ 0.80 lesions. This hypothesis
also would need further exploration in a larger
prospective study.
Finally, it is important to highlight that IVUS-VH
and FFR are two different ways to evaluate the
significance of a coronary plaque. While FFR is a
standardized method evaluating the functional sig-
nificance of an intermediate coronary stenosis, IVUS-
VH analysis provides information on the plaque size
and on its tissue characterization through its back-
scattering signal. As virtual histology is a sound-
based imaging modality using the radiofrequency
data to compute 4 different tissue types, it suffers
from all limitations as any other ultrasound-derived
techniques. While the use of FFR to decide the
percutaneous treatment of a coronary lesion has been
widely described and correlated with long-term
prognosis [13, 34], the use of VH to decide a
percutaneous treatment of a coronary plaque is not
Table 2 IVUS-VH data
Data are expressed as
mean ± standard deviation.










(n = 38 lesions)
FFR B 0.80
(n = 17 lesions)
P value
IVUS-VH data
Mean plaque area (mm2) 8.6 ± 2.6 8.9 ± 3.5 0.8
Plaque burden (%) 51.7 ± 0.7 54.6 ± 0.7 0.1
Mean lumen area (mm2) 7.9 ± 2.4 7.1 ± 1.8 0.1
Minimum lumen area (mm2) 5.6 ± 2.3 4.6 ± 1.2 0.07
Mean vessel area (mm2) 16.5 ± 4.4 16.0 ± 5.0 0.4
Fibrous tissue (mm2) 2.7 ± 1.4 3.0 ± 1.8 0.6
Fibrous tissue (%) 54.5 ± 10.7 57.3 ± 6.7 0.2
Fibrofatty tissue (mm2) 0.8 ± 0.8 1.2 ± 1.1 0.07
Fibrofatty tissue (%) 15.1 ± 11.1 21.5 ± 10.8 0.02
Necrotic core tissue (mm2) 0.9 ± 0.5 0.7 ± 0.4 0.2
Necrotic core tissue (%) 19.2 ± 10.2 14.2 ± 8.0 0.08
Dense calcium (mm2) 0.5 ± 0.4 0.3 ± 0.3 0.1
Dense calcium (%) 11.0 ± 8.3 6.8 ± 4.8 0.1
VH plaque distribution 0.7
PIT, n (%) 6 (15) 3 (17)
FC, n (%) 2 (8) 0 (0)
FA, n (%) 4 (10) 3 (17)
CaFA, n (%) 5 (13) 1 (8)
TCFA, n (%) 6 (15) 3 (17)
CaTCFA, n (%) 15 (39) 7 (41)
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Fig. 1 Examples of various type of VH-plaque found in the
analysis with the corresponding IVUS appearance. Lumen
contour (yellow line) and vessel contour (red line) are shown.
In the VH images, necrotic core is coded as red, dense calcium
as white, fibrous tissue as dark green and fibrofatty tissue as
light green. PIT pathological intimal thickening, FC fibrocal-
cific plaque, FA fibroatheroma, TCFA thin-cap fibroatheroma,
CaFA calcified fibroatheroma, CaTCFA calcified thin-cap
fibroatheroma
Fig. 2 Examples of two different lesions (white arrows) with a FFR [ 0.80 (panel A) and B0.80 (panel B), both showing a FA VH-
plaque type. In the IVUS images red and yellow contours indicate vessel and lumen contours, respectively
Int J Cardiovasc Imaging
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well investigated yet. The SECRITT-I trial is ongoing
to test the efficacy of preventive treatment of a NC-
rich plaque with a self-expanding stent, that allows
the formation of a fibrous cap [35].
Limitations
This is a registry study and included a small number of
patients. No clinical or angiographic follow-up are
available. Our findings only focused on ambiguous/
equivocal lesions were the use of FFR was considered
of value in the clinical decision process. Whether other
lesions causing less significant stenosis have different
composition as compared with hemodinamically sig-
nificant lesions will require additional studies.
Conclusions
Coronary lesions with FFR more or less than 0.80 are
not different in terms of plaque composition and
virtual histology plaque types from their counterparts.
The hypothesis of whether a preventive treatment
might be required for those patients who have a NC-
rich plaque with FFR [ 0.80 needs to be further
explored.
Conflict of interest None of the authors have any conflict of
interest to declare.
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